Innovative & Impowered Antibody Based Therapy, Led by Seattle Genetics CEO

In the world of cancer research, knowledge is the key to success. Having such knowledge can help the industry expand more so in the development of treatments or possible cures. Cancer is very prevalent in today’s society and it’s deadly wrath can be felt among us all whether it being a family member, friend, or associate. Luckily there have been some great advancements in the fight against cancer and it comes in the form of Antibody Based Treatments. These innovative treatments are much more effective than traditional treatments such as Chemotherapy and patients will experience a lack of sickening side effects after the treatments are over. Cancer Research has a much better prognosis and as innovation gets better, more and more lives will be saved.

Dr. Clay Siegall whom is the President and CEO of Seattle Genetics, is doing a great job for bringing new and innovative technology to modern day medicine. Dr. Siegall has a progressive approach that has yielded great results. Scientific innovation, drug development, and rigorous research is what he and the company stands by. Having much experience in the field, Dr. Siegall has transcended Seattle Genetics to a more mainstream market rather staying private. As you can see he is very accomplished in his own rights, but Dr. Clay Siegall’s passion isn’t about earning new accolades, but more so helping others.

Seattle Genetics is located in Bothell, Washington and it’s one of the area’s biggest job producers. With over 800 employees all ready to work; the company’s growth in revenue will likely increase the need or more hiring. Antibody Based Therapy is the future of fighting cancer and Dr. Clay Siegall is in firm control of it’s future outcome.